Heterocyclidene-N-(aryl)acetamide derivative

Details for Australian Patent Application No. 2008208224 (hide)

Owner Mochida Pharmaceutical Co., Ltd.

Inventors Makabe, Muneyoshi; Ogawa, Shinichi; Maeda, Yoshitaka; Uchida, Hideharu

Agent Spruson & Ferguson

Pub. Number AU-A-2008208224

PCT Pub. Number WO2008/091021

Priority 2007-014372 24.01.07 JP

Filing date 24 January 2008

Wipo publication date 31 July 2008

International Classifications

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/5355 (2006.01) - Non-condensed oxazines containing further heterocyclic rings

A61K 31/536 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems

A61K 31/538 (2006.01)

A61K 31/5415 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

13 August 2009 PCT application entered the National Phase

  PCT publication WO2008/091021 Priority application(s): WO2008/091021

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008208288-Genetically recombinant antibody composition having enhanced effector activity

2008208151-Topical formulation